January 31, 2015 8:32 AM ET


Company Overview of Nereus Pharmaceuticals, Inc.

Company Overview

Nereus Pharmaceuticals, Inc., a drug discovery and development company, identifies and synthesizes biologically active compounds and drug candidates derived from marine microbiology and integrated technologies. It offers oncology drug candidates, such as Plinabulin (NPI-2358), a tumor vascular disrupting agent for non-small cell lung carcinoma; and NPI-0052, a proteasome inhibitor for the treatment of multiple myeloma, solid tumors, lymphomas, and leukemias. The company also provides IKK Series, a portfolio of synthetic small molecule diterpene derived analogues that modulate NF-kB/IKK activity to impact the disease related activation of NF-kB that are implicated in the resistance of cancers...

10480 Wateridge Circle

San Diego, CA 92121

United States

Founded in 1998





Key Executives for Nereus Pharmaceuticals, Inc.

Scientific Co-Founder
Vice President of Finance & Administration
Scientific Co-Founder
Chief Scientific Officer and Senior Vice President of R & D
Age: 70
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Asuragen, Inc. United States
X-BODY, Inc United States
QT Holdings Corp. United States
Arsia Therapeutics, Inc. United States
Prolong Pharmaceuticals, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Nereus Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.